DOI: 10.1515/mr-2022-0037
Precision intervention of cell type-specific targeting is required for future cancer immunotherapy
Yitong Cai1
Anli Zhang2
Changzheng Lu3
1.Institute of Cancer Research,Shenzhen Bay Laboratory,Shenzhen,Guangdong Province,China2.Lyda Hill Department of Bioinformatics,UT Southwestern Medical Center,Dallas,TX,USA3.Institute of Cancer Research,Shenzhen Bay Laboratory,Shenzhen 518132,Guangdong Province,China
摘要：Immune checkpoint blockade has represented a break-through for the treatment of human cancers, but only a minority of patients obtain clinical benefits from this therapy. A critical issue is how to shape the "cold" tumor, characterized by desert or suppressive immunity, into a"hot" phenotype [1].
机标关键词：immunotherapyprecisionfuturecancercellinterventionrequiredtargeting
论文发表日期：2022-12-28
在线出版日期：2025-08-15（本平台首次上网日期，不代表文献的发表时间）
页数：2( 553-554 )